{
  "cik": 1611115,
  "cik_padded": "0001611115",
  "entityName": "Omada Health, Inc.",
  "fiscal_years": [
    {
      "accn": "0001628280-26-015637",
      "filed": "2026-03-06",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1322000.0,
        "cash": 222036000.0,
        "cost_of_revenue": 89271000.0,
        "eps_diluted": -0.35,
        "free_cash_flow": 16930000.0,
        "gross_profit": 170939000.0,
        "net_income": -12778000.0,
        "operating_cash_flow": 18252000.0,
        "operating_income": -11972000.0,
        "revenue": 260210000.0,
        "stockholders_equity": 229680000.0,
        "total_assets": 305406000.0,
        "total_liabilities": 75726000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "gross_margin": 0.6569270973444525,
        "leverage": 0.32970219435736675,
        "net_margin": -0.04910649091118712,
        "operating_margin": -0.04600899273663579,
        "revenue_growth_yoy": 0.5324499411071849,
        "roa_avg2y": -0.056007258414457216,
        "roa_period_end": -0.04183938756933394,
        "roe_avg2y": 0.16517259877329163,
        "roe_period_end": -0.05563392546151167
      }
    },
    {
      "accn": "0001628280-26-015637",
      "filed": "2026-03-06",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 596000.0,
        "cash": 76392000.0,
        "cost_of_revenue": 66923000.0,
        "eps_diluted": -6.11,
        "free_cash_flow": -34775000.0,
        "gross_profit": 102877000.0,
        "net_income": -47137000.0,
        "operating_cash_flow": -34179000.0,
        "operating_income": -43654000.0,
        "revenue": 169800000.0,
        "stockholders_equity": -384403000.0,
        "total_assets": 150892000.0,
        "total_liabilities": 86261000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "gross_margin": 0.6058716136631331,
        "net_margin": -0.277603062426384,
        "operating_margin": -0.2570906949352179,
        "revenue_growth_yoy": 0.38291634089132137,
        "roa_period_end": -0.3123889934522705,
        "roe_avg2y": 0.12834863821705478
      }
    },
    {
      "accn": "0001628280-26-015637",
      "filed": "2026-03-06",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "capex": 416000.0,
        "cost_of_revenue": 52813000.0,
        "eps_diluted": -9.52,
        "free_cash_flow": -50154000.0,
        "gross_profit": 69971000.0,
        "net_income": -67511000.0,
        "operating_cash_flow": -49738000.0,
        "operating_income": -65997000.0,
        "revenue": 122784000.0,
        "stockholders_equity": -350112000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "gross_margin": 0.5698706671879072,
        "net_margin": -0.5498354834506125,
        "operating_margin": -0.5375048866301798,
        "roe_avg2y": 0.20989485204046734
      }
    },
    {
      "accn": "0001628280-26-015637",
      "filed": "2026-03-06",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -293172000.0
      },
      "period_end": "2022-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001628280-26-015637",
    "filed": "2026-03-06",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "8000",
  "sic_description": "Services-Health Services",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001611115.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001611115.json"
  },
  "ticker": "OMDA"
}